| scholarly article | Q13442814 |
| P50 | author | John R. Engen | Q50420861 |
| Loren D. Walensky | Q92710996 | ||
| P2093 | author name string | Thomas E Wales | |
| Daniel T Cohen | |||
| Matthew W McHenry | |||
| P2860 | cites work | Structural model of active Bax at the membrane. | Q42166522 |
| Preparation of Very-High-Yield Recombinant Proteins Using Novel High-Cell-Density Bacterial Expression Methods | Q42949018 | ||
| Dissection of the BCL-2 family signaling network with stabilized alpha-helices of BCL-2 domains | Q46500385 | ||
| Crystal Structures of Anti-apoptotic BFL-1 and Its Complex with a Covalent Stapled Peptide Inhibitor. | Q47257058 | ||
| Precision Targeting of BFL-1/A1 and an ATM Co-dependency in Human Cancer | Q61570952 | ||
| Tritium-hydrogen exchange studies of protein models. I. Gramicidin S-A | Q72409362 | ||
| Nonionic detergents induce dimerization among members of the Bcl-2 family | Q73343305 | ||
| Hierarchical regulation of mitochondrion-dependent apoptosis by BCL-2 subfamilies | Q79370601 | ||
| NMR methods for studying protein-protein interactions involved in translation initiation | Q81390819 | ||
| Chemical Probe to Identify the Cellular Targets of the Reactive Lipid Metabolite 2- trans-Hexadecenal | Q88243721 | ||
| Recent Advances in Selective and Irreversible Covalent Ligand Development and Validation | Q90828951 | ||
| Targeting BAX to drug death directly | Q92826559 | ||
| Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis | Q24306444 | ||
| A stapled BID BH3 helix directly binds and activates BAX | Q24307663 | ||
| Bax crystal structures reveal how BH3 domains activate Bax and nucleate its oligomerization to induce apoptosis | Q24313049 | ||
| Membrane binding by tBid initiates an ordered series of events culminating in membrane permeabilization by Bax | Q24323186 | ||
| BAX unleashed: the biochemical transformation of an inactive cytosolic monomer into a toxic mitochondrial pore | Q27002044 | ||
| Structure of Bax: coregulation of dimer formation and intracellular localization | Q27628839 | ||
| BAX activation is initiated at a novel interaction site | Q27652635 | ||
| Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis | Q27734734 | ||
| Protein production by auto-induction in high density shaking cultures | Q27860514 | ||
| Hydrogen exchange mass spectrometry for the analysis of protein dynamics | Q28275804 | ||
| Dual role of proapoptotic BAD in insulin secretion and beta cell survival | Q28586275 | ||
| Posttranslational N-myristoylation of BID as a molecular switch for targeting mitochondria and apoptosis | Q28647600 | ||
| An inhibitor of Bcl-2 family proteins induces regression of solid tumours | Q29547595 | ||
| Auto-activation of the apoptosis protein Bax increases mitochondrial membrane permeability and is inhibited by Bcl-2 | Q30493313 | ||
| The multidomain proapoptotic molecules Bax and Bak are directly activated by heat | Q34212713 | ||
| Conformational rearrangements in the pro-apoptotic protein, Bax, as it inserts into mitochondria: a cellular death switch | Q34552749 | ||
| Evidence for the presence of hydrogen-bonded secondary structure in angiotensin II in aqueous solution | Q34688172 | ||
| The BCL-2 family reunion | Q35568029 | ||
| Cysteine 62 of Bax is critical for its conformational activation and its proapoptotic activity in response to H2O2-induced apoptosis | Q35674492 | ||
| Small molecules reveal an alternative mechanism of Bax activation. | Q35936239 | ||
| Allosteric inhibition of antiapoptotic MCL-1. | Q36012325 | ||
| Sphingolipid metabolism cooperates with BAK and BAX to promote the mitochondrial pathway of apoptosis | Q36422392 | ||
| Hydrogen exchange-mass spectrometry measures stapled peptide conformational dynamics and predicts pharmacokinetic properties | Q37442733 | ||
| Chemoproteomic profiling and discovery of protein electrophiles in human cells | Q37664926 | ||
| Stepwise activation of BAX and BAK by tBID, BIM, and PUMA initiates mitochondrial apoptosis. | Q38268983 | ||
| The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models | Q38736457 | ||
| Revealing oxidative damage to enzymes of carbohydrate metabolism in yeast: An integration of 2D DIGE, quantitative proteomics, and bioinformatics | Q39755679 | ||
| Bcl-2/Bax: a rheostat that regulates an anti-oxidant pathway and cell death | Q40732702 | ||
| Selective Covalent Targeting of Anti-Apoptotic BFL-1 by Cysteine-Reactive Stapled Peptide Inhibitors. | Q41374031 | ||
| Inhibition of Pro-apoptotic BAX by a noncanonical interaction mechanism. | Q41432708 | ||
| BH3-triggered structural reorganization drives the activation of proapoptotic BAX. | Q41884328 | ||
| Analysis of protein conformation and dynamics by hydrogen/deuterium exchange MS. | Q41910169 | ||
| S-palmitoylation represents a novel mechanism regulating the mitochondrial targeting of BAX and initiation of apoptosis | Q42003162 | ||
| P433 | issue | 10 | |
| P304 | page(s) | 3229-3239.e6 | |
| P577 | publication date | 2020-03-01 | |
| P1433 | published in | Cell Reports | Q5058165 |
| P1476 | title | Site-Dependent Cysteine Lipidation Potentiates the Activation of Proapoptotic BAX | |
| P478 | volume | 30 |
| Q97531409 | A redox switch regulates the structure and function of anti-apoptotic BFL-1 | cites work | P2860 |
Search more.